IP Library Granted Patent US 9,445,867
Granted Patent B1
US 9,445,867 · App. 15/075,789 · Granted Sep 20, 2016

Methods for renal neuromodulation via catheters having expandable treatment members

Inventors: Denise Zarins (Saratoga, CA); Hanson Gifford, III (Woodside, CA); Mark Deem (Mountain View, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY); Nicolas Zadno (Fremont, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/1492A61B18/12A61N1/0551A61B2018/00267A61B2018/00404A61B2018/00434A61B2018/00577A61B2018/00613A61B2018/00642A61B2018/00648A61B2018/00791
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,445,867
App. No.
15/075,789
Granted
Sep 20, 2016
Kind
B1
Abstract

Methods and apparatus are provided for monopolar neuromodulation, e.g., via a pulsed electric field. Such monopolar neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, monopolar neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such monopolar neuromodulation is performed bilaterally.

Claims (33)

1. A method, comprising:

intravascularly positioning a renal denervation catheter in a reduced profile delivery configuration within a renal artery of a human patient and adjacent to renal nerves;

transforming an expandable member at a distal region of the catheter from the low-profile delivery configuration to a treatment configuration, wherein, in the treatment configuration, the expandable member is sized and shaped to place a plurality of electrodes arranged thereabout into apposition with an inner wall of the renal artery of the patient;

selectively energizing a first electrode group carried by the expandable member to deliver a first bipolar energy field to the renal nerves; and

selectively energizing a second electrode group carried by the expandable member to deliver a second bipolar energy field to the renal nerves,

wherein delivering the first and second bipolar energy fields blocks or attenuates neural signaling along the renal nerves.

2. The method of claim 1 wherein the expandable member comprises a basket having a plurality of struts, and wherein transforming the expandable member from the low-profile delivery configuration to the treatment configuration comprises expanding the basket such that electrodes arranged along the individual struts are placed into apposition with the inner wall of the renal artery.

3. The method of claim 2 wherein the basket is composed of nitinol.

4. The method of claim 2 wherein the basket comprises a laser-cut hypotube.

5. The method of claim 2 wherein the basket is positioned within the renal artery in the low-profile delivery configuration within a delivery sheath, and wherein the basket is configured to self-expand to the treatment configuration upon removal from the sheath.

6. The method of claim 2 wherein the individual electrodes are affixed to an outside surface of corresponding struts of the basket, and wherein each strut includes at least one electrode.

7. The method of claim 1 wherein the expandable member comprises a balloon, and wherein transforming the expandable member from the low-profile delivery configuration to the treatment configuration comprises expanding the balloon such that electrodes arranged thereabout are placed into contact with the inner wall of the renal artery.

8. The method of claim 7 wherein transforming the balloon from the low-profile delivery configuration to the treatment configuration comprises occluding blood flow within the renal vessel while the balloon is in the treatment configuration.

9. The method of claim 1 wherein blocking or attenuating neural signaling along the renal nerves results in a therapeutically beneficial reduction in blood pressure of the patient.

10. The method of claim 1 wherein selectively energizing the first electrode group and selectively energizing the second electrode group occurs simultaneously.

11. The method of claim 1 wherein selectively energizing the first electrode group and selectively energizing the second electrode group occurs sequentially.

12. The method of claim 1 wherein intravascularly positioning a catheter in a reduced profile delivery configuration within a renal artery of the patient comprises delivering the catheter over a guidewire.

13. The method of claim 1 , further comprising monitoring a parameter of the catheter and/or tissue within the patient before and during delivery of the first and second bipolar energy fields.

14. The method of claim 13 wherein monitoring a parameter comprises monitoring temperature, power, and/or impedance.

15. The method of claim 13 , further comprising altering delivery of at least one of the first and second bipolar energy fields in response to the monitored parameter.

16. The method of claim 13 wherein monitoring a parameter comprises monitoring temperature of the tissue, and wherein the method further comprises maintaining the tissue at a desired temperature during delivery of the first and second bipolar energy fields.

17. The method of claim 1 wherein delivering the first and second bipolar energy fields to the renal nerves comprises partially ablating the renal nerves of the patient.

18. The method of claim 1 wherein delivering the first and second bipolar energy fields to the renal nerves comprises ablating one or more renal nerves of the patient.

19. The method of claim 1 wherein delivering the first and second bipolar energy fields to the renal nerves comprises thermally altering the renal nerves in a manner that reduces neural traffic to and from a kidney of the patient.

20. A method for treating a hypertensive human patient, the method comprising:

positioning an expandable member of a renal denervation catheter at an intravascular location within a renal artery of a human patient and adjacent to neural fibers innervating a kidney of the patient;

transforming the expandable member from a low-profile delivery state to an expanded treatment state wherein, in the treatment state, the expandable member is sized to place a first set of electrodes carried by a first region of the expandable member and a second set of electrodes carried by a second, different region of the expandable member in contact with target tissue at or near the neural fibers; and

ablating the neural fibers innervating the kidney via radio frequency (RF) energy delivered from the first and second sets of electrodes.

21. The method of claim 20 wherein positioning an expandable member of a renal denervation catheter within a renal artery comprises positioning an expandable basket carrying the first and second sets of electrodes within the renal artery.

22. The method of claim 20 wherein positioning an expandable member of a renal denervation catheter within a renal artery comprises positioning a balloon carrying the first and second sets of electrodes within the renal artery.

23. The method of claim 20 wherein ablating the neural fibers innervating the kidney results in a therapeutically beneficial reduction in blood pressure of the patient.

24. The method of claim 20 , further comprising monitoring a parameter of the renal denervation catheter and/or tissue within the patient before and during delivery of the RF energy.

25. The method of claim 24 wherein monitoring a parameter comprises monitoring temperature, power, and/or impedance, and wherein the method further comprises altering delivery or the RF energy in response to the monitored parameter.

Continuity (15)
Continuation 14611651 · Feb 2, 2015
Continuation 13958450 · Aug 2, 2013
Continuation 13371285 · Feb 10, 2012
Division 11403329 · Apr 13, 2006
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11363867 · Feb 27, 2006
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60813589 · Dec 29, 2005